Is the dietary supplement industry getting a handle on the adulteration issue? The baseline data does not exist to be able to say one way or another. But sources agree that in the one thing you can measure—the attention the issue is getting—the situation...
The Center for Science in the Public Interest has called on the Food and Drug Administration to ban the sale of high potency caffeine products to consumers. Despite FDA’s warning letters of last year, the products are still widely for sale, CSPI said.
The US Food and Drug Administration tells NutraIngredients-USA that it looks forward to learning more about the Council for Responsible Nutrition’s proposed industry-wide dietary supplement product registry.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is alarmed that FDA has taken so long to act against manufacturers of supplements containing methylsynephrine / oxilofrine.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is seeking a comprehensive list of enforcement actions taken by the Department of Justice related to the dietary supplement industry.
Scott Bass, partner, Sidley Austin LLP, and Steve Mister, President & CEO of the Council for Responsible Nutrition (CRN), will co-chair the Fourth Annual Legal, Regulatory, and Compliance Forum on Dietary Supplements.